Scotland · NHS Scotland MSAN
Naloxegol (Moventig®) 12.5mg and 25mg tablets
MSAN(2024)17 · Level 2 · issued 25 Apr 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Naloxegol (Moventig®) 12.5mg tablets are out of stock until early August 2024. | Out of stock | early August 2024 |
| 2. Naloxegol (Moventig®) 25mg tablets are out of stock until the end of April 2024. | Out of stock | the end of April 2024 |
| 3. Naldemedine (Rizmoic®) 200 micrograms tablets remain available and can support increased | Available | — |
| film-coated and unscored; no data are available on halving them, and this manipulation would | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.